Use Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive Therapies

Completed · Not applicable

Conditions studied: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Non-Hodgkin Lymphoma

In brief

This is a pilot study to evaluate the use feasibility of the iThermonitor, a continuous temperature monitoring device, as a clinical support and patient self-management tool in the management of pediatrics patients on myelosuppressive therapies for acute leukemia and other childhood cancers.

Key facts

Study ID

NCT02410252

Run by

Massachusetts General Hospital

People needed

25

Starts

2015-05-01

Expected to finish

2017-08-01

Last updated by the study team

2020-10-22

Who can join

Age: 2 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Dyad consists of a pediatric patient aged 2-17 years undergoing myelosuppressive therapies for acute leukemias and other childhood cancers.
• Dyad also includes a caregiver, ≥ 18 years of age that is willing to participate in the study.
• Ability of caregiver or patient (if old enough) to read and speak English.
• If applicable, willingness of the patient to shave axillary (armpit) hair.
• Caregiver (parent or legal guardian) must give informed consent for dyad participation.

You may not qualify if…

• Patient has a history of allergy to hydrogel dressing or ongoing skin diseases
• Patients with ongoing febrile illness or documented infectious disease.

Where it is running

• Amanda Centi — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.